Zika Virus Non-Structural Protein NS5 Inhibits the RIG-I Pathway and Interferon Lambda 1 Promoter Activation by Targeting IKK Epsilon

Lundberg,Melén,Westenius,Jiang,Österlund,Khan,Vapalahti,Julkunen,Kakkola

DOI: https://doi.org/10.3390/v11111024

2019-11-04

Viruses

Abstract:The Zika virus (ZIKV) is a member of the Flaviviridae family and an important human pathogen. Most pathogenic viruses encode proteins that interfere with the activation of host innate immune responses. Like other flaviviruses, ZIKV interferes with the expression of interferon (IFN) genes and inhibits IFN-induced antiviral responses. ZIKV infects through epithelial barriers where IFN-λ1 is an important antiviral molecule. In this study, we analyzed the effects of ZIKV proteins on the activation of IFN-λ1 promoter. All ZIKV proteins were cloned and transiently expressed. ZIKV NS5, but no other ZIKV protein, was able to interfere with the RIG-I signaling pathway. This inhibition took place upstream of interferon regulatory factor 3 (IRF3) resulting in reduced phosphorylation of IRF3 and reduced activation of IFN-λ1 promoter. Furthermore, we showed that ZIKV NS5 interacts with the protein kinase IKKε, which is likely critical to the observed inhibition of phosphorylation of IRF3.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how the Zika virus (ZIKV) non - structural protein NS5 inhibits the host's innate immune response, especially the activation of the RIG - I signaling pathway and interferon - λ1 (IFN - λ1) promoter. Specifically, the research aims to:

1. **Analyze the influence of ZIKV proteins on the activation of IFN - λ1 promoter**: By cloning and transiently expressing all ZIKV proteins, study their potential inhibitory effects on the RIG - I signaling pathway and the activation of IFN - λ1 promoter.

2. **Determine the role of ZIKV NS5 in inhibiting the RIG - I signaling pathway**: The research found that ZIKV NS5 can interfere with the RIG - I signaling pathway. This inhibition occurs before the phosphorylation of IRF3, resulting in a decrease in IRF3 phosphorylation and a decrease in the activation of IFN - λ1 promoter.

3. **Reveal the interaction between ZIKV NS5 and IKKε**: Further research shows that ZIKV NS5 interacts with the protein kinase IKKε, which may be a key mechanism for its ability to inhibit IRF3 phosphorylation.

4. **Verify the inhibitory effect of ZIKV NS5 on the IFN - induced pathway**: Through experiments, verify whether ZIKV NS5 directly acts on the RIG - I signaling pathway, rather than inhibiting the activation of IFN - λ1 and IFN - β promoters through the interferon - induced feedback loop.

In conclusion, the main purpose of this paper is to clarify how ZIKV NS5 inhibits the RIG - I signaling pathway and the activation of IFN - λ1 promoter by interacting with IKKε, thereby helping the virus evade the host's innate immune response.